Grail, originally a spinoff of Illumina, develops early-detection cancer diagnostics using blood samples, which the genomics company seeks to add back into its biotech arsenal. However, both the European Commission...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)